A carregar...

Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab

The increased propensity of BRCA1 mutation carriers to develop aggressive breast tumors with stem-like properties begins to be understood in terms of osteoprotegerin (OPG)-unrestricted cross-talk between RANKL-overproducing progesterone-sensor cells and cancer-initiating RANK(+) responder cells that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Cycle
Main Authors: Cuyàs, Elisabet, Martin-Castillo, Begoña, Bosch-Barrera, Joaquim, Menendez, Javier A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499830/
https://ncbi.nlm.nih.gov/pubmed/28387573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2017.1310353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!